Mindbloom
The largest at-home ketamine therapy platform, offering sublingual and injectable ketamine for depression, anxiety, and PTSD across 35 states.
What we like
What to watch
Full Review
Mindbloom is the most established at-home ketamine therapy provider, having facilitated ~600,000 dosing sessions since its 2019 virtual launch. Backed by $44.9M from Kleiner Perkins, Founders Fund, and 8VC, the company offers sublingual troches and subcutaneous injectable ketamine with clinician oversight and guide coaching. Published peer-reviewed research (Journal of Affective Disorders, 11,441-patient study) shows ~56-63% improvement in depression and anxiety within 4 sessions. However, the company faces a wrongful death lawsuit (Oct 2025) involving ketamine toxicity and an $88M defamation suit against the Wall Street Journal. Billing complaints and poor BBB ratings remain a consistent drag on reputation despite strong Trustpilot scores.
Last researched: 2026-03-31
Pricing
Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| 6-Session Program (3 months) | Mental Health | $430 | ● Consults○ Lab work● Shipping | Subscription required |
| 12-Session Program (6 months) | Mental Health | $370 | ● Consults○ Lab work● Shipping | Subscription required |
| 18-Session Program (9 months) | Mental Health | $330 | ● Consults○ Lab work● Shipping | Subscription required |
| Returning Client 6-Session | Mental Health | $318 | ● Consults○ Lab work● Shipping | Subscription required |